False/Negative Rate of Lung Percutaneous Needle Biopsy
Determination of the False Negative Rate of Percutaneous Needle Biopsies That Include Core Tissue Samples
Sponsor: State University of New York - Upstate Medical University
This observational or N/A phase trial investigates Lung Neoplasm and is currently completed. State University of New York - Upstate Medical University leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2024 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Jan 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- State University of New York - Upstate Medical University
For direct contact, visit the study record on ClinicalTrials.gov .